Income statement (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Fiscal period length | 12 | 12 | 12 | 12 | 12 |
Net sales | |||||
Gross profit | -8.44 | -9.38 | -8.85 | -7.20 | -7.51 |
EBIT | -8.44 | -9.38 | -8.85 | -7.20 | -7.51 |
Other financial income | 1.33 | 7.67 | |||
Other financial expenses | -13.14 | -15.87 | -14.78 | -18.54 | -29.27 |
Income from other inv. held as non-curr. assets | 170.00 | 72.01 | 110.00 | 150.00 | |
Pre-tax profit | 148.42 | -25.24 | 49.72 | 84.27 | 120.88 |
Net earnings | 148.42 | -25.24 | 49.72 | 84.27 | 120.88 |
Assets (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Intangible assets total | |||||
Tangible assets total | |||||
Investments total | |||||
Non-current loans receivable | 650.00 | 650.00 | 654.00 | 654.00 | 695.59 |
Long term receivables total | 650.00 | 650.00 | 654.00 | 654.00 | 695.59 |
Inventories total | |||||
Current other receivables | 101.33 | 100.00 | 207.67 | ||
Short term receivables total | 101.33 | 100.00 | 207.67 | ||
Balance sheet total (assets) | 650.00 | 650.00 | 755.33 | 754.00 | 903.26 |
Equity and liabilities (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Share capital | 50.00 | 50.00 | 50.00 | 50.00 | 50.00 |
Shares repurchased | 114.40 | 117.80 | 122.00 | ||
Retained earnings | 35.39 | 183.81 | 44.17 | -23.91 | -61.64 |
Profit of the financial year | 148.42 | -25.24 | 49.72 | 84.27 | 120.88 |
Shareholders equity total | 233.81 | 208.57 | 258.29 | 228.16 | 231.24 |
Non-current liabilities total | |||||
Current loans from credit institutions | 366.70 | 365.69 | 378.77 | 293.00 | 317.53 |
Current trade creditors | 6.00 | 6.00 | 6.00 | 6.00 | 6.00 |
Other non-interest bearing current liabilities | 43.48 | 69.74 | 112.27 | 226.84 | 348.49 |
Current liabilities total | 416.19 | 441.43 | 497.04 | 525.84 | 672.01 |
Balance sheet total (liabilities) | 650.00 | 650.00 | 755.33 | 754.00 | 903.26 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.